HIV Malignancy Study
The Characteristics of HIV-positive Adults with and without Diagnoses of Malignancy Attending Three HIV Clinics in Sydney, Australia
Since the start of HIV/AIDS in early 1980s, HIV-positive adults have been recognised to be at increased risk of malignancy in comparison to the general population. During the pre-HAART era, AIDS-defining conditions, including malignancies such as Kaposi sarcoma, non-Hodgkin's lymphoma, and cervical cancer, contributed significantly to morbidity and mortality; however, the introduction of HAART in the mid 1990s has significantly reduced this burden, with the emergence of non-AIDS defining malignancies as major causes of morbidity and mortality.
This study aims to describe such an evolving and changing spectrum of malignancies over the entire period of the epidemic (1980-2009). It aims also to characterise the demographic, immunologic, and clinical features of HIV-positive adults with malignancy.
For more information about this study, Nader can be contacted via:
Dr Nader Shalaka
Nader Shalaka is an International Medical Graduate (IMG) who has completed his Bachelors Degree in Medicine and Surgery (MB ChB) at Alfateh University, Tripoli, Libya. In 2008 Nader was granted a scholarship for postgraduate study in Medicine, and in 2009 he completed a Masters Degree in Medicine (Infection and Immunity) at The University of Sydney.
During his Masters course, Nader became interested in HIV infection and the link between immuosuppression and the risk of cancer. He is currently undertaking an MPhil in HIV-related cancers.